Prelude Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211K Sell
43,133
-8,467
-16% -$49.7K 0.02% 1067
2026
Q2
$249K Buy
51,600
+41,600
+416% +$251K 0.02% 871
2026
Q1
$61.6K Buy
+10,000
New +$83K ﹤0.01% 1108

Other funds holding RXST

Prelude Capital Management's RXST Position: Q3 2026 in Review

Prelude Capital Management reduced its RxSight (RXST) stake by 16% in Q3 2026, selling an estimated $49.7K and leaving 43,133 shares worth $211K. The position accounts for 0.02% of the portfolio, ranked #1067.

Prelude Capital Management first reported a position in RXST in Q1 2026 and has held it in 3 quarters since. The position peaked at $249K in Q2 2026. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.

  • Prelude Capital Management held 43,133 shares of RxSight worth $211K as of Q3 2026.
  • Prelude Capital Management sold 8,467 RxSight shares in Q3 2026, an estimated $49.7K.
  • RxSight made up 0.02% of Prelude Capital Management's portfolio in Q3 2026, its #1067 holding.
  • Prelude Capital Management first reported a position in RxSight in Q1 2026 and has held it in 3 quarters since.
  • Prelude Capital Management's RxSight position peaked at $249K in Q2 2026.
  • 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.

Based on Prelude Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.